Related Experiment Video
Updated: Oct 25, 2025
06:13
Author Spotlight: Insights into Remotely Supervised Neuromodulation Procedure for Phantom Limb Pain
Published on: March 1, 2024
1.1K
Introduction of digital therapeutics
Ji Sun Hong1, Chris Wasden2, Doug Hyun Han1
1Department of Psychiatry, Chung-Ang University Hospital, 102 Heukseok-ro, Dongjak-gu, Seoul 06973, Republic of Korea.
Computer Methods and Programs in Biomedicine
|August 7, 2021
Summary
Digital therapeutics offer flexible, software-based interventions for various health conditions. While the market expands globally, regulatory and user-centered approaches are crucial for widespread adoption.
Area of Science:
- Digital health
- Medical informatics
- Therapeutic technologies
Background:
- Digital therapeutics (DTx) are evidence-based software interventions for medical conditions.
- DTx address a range of conditions including diabetes, oncology, and neuropsychiatric disorders.
- DTx offer personalized treatment flexibility.
Purpose of the Study:
- To review the current landscape of digital therapeutics.
- To examine market trends and regulatory considerations for DTx.
- To identify challenges and future directions for DTx adoption.
Main Methods:
- Literature review of digital therapeutics products and market analysis.
- Examination of regulatory policies in key global markets (US, EU, Asia).
- Analysis of factors influencing DTx adoption.
Main Results:
- The digital therapeutics market is experiencing global expansion, driven by demand for advanced medical solutions.
- Numerous DTx products are commercially available for conditions like insomnia, anxiety, and diabetes, though not FDA-cleared.
- Regulatory bodies in the EU and Asia are developing frameworks for DTx.
Conclusions:
- Adoption of digital therapeutics is complex, involving multiple stakeholders and value judgments.
- Further investigation into user-centered approaches and technical support is needed for successful real-world implementation.
- Policy development is crucial for integrating DTx into healthcare systems.
Related Concept Videos
01:29Therapeutic Drug Monitoring: Affecting Factors
37
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
37
01:16Therapeutic Drug Monitoring: Overview and Classification
49
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
49
02:50Combination Therapies and Personalized Medicine
5.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
01:29Issues And Trends In Healthcare Delivery System
5.9K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.9K
01:26Drug Administration and Therapy Phases: Overview
886
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
886
01:28Drug Therapy
123
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
123